PRESS RELEASES AND NEWS
Velóce press releases
04.05.2019-Velóce Corporation using our proprietary SmartTab wireless powered and controlled ingestible capsule completes successful Pre-Clinical Animal studies. The results will be published in peer reviewed Scientific Journals later this year. This is a large milestone with significant progress towards FDA submission and approval.
01.10.2019-Velóce Corporation attends the StartUp Health/JP Healthcare Conference in San Francisco.
10.14.2018-Velóce Digital Health has now moved into the new Catalyst HTI building. Located in Denver, Colorado’s River North District (RiNo), Catalyst HTI is bringing together private enterprise (startups to Fortune 100), government, academic and non-profit organizations with healthcare providers and payers to accelerate innovation and drive real, lasting change.
09.28.2018-Velóce Digital Health is pleased to announce the hiring of a new Chief Technology Officer, Douglas Miller. Doug has 30+ years of medical device/wireless design and development, FDA, and Quality Systems. Doug has taken numerous products from concept to commercialization including regulatory approvals. Doug has a PhD in Biomedical Engineering and a Bachelor of Science in Electrical Engineering.
08.21.2017-Velóce Corporation has received the next issued notification of patent allowance from the United States Patent and Trademark Office. Patent issued as U.S Patent No. 9,750,923, "Wireless Communications System Integrating Electronics into Orally Ingestible Products for Controlled Release of Active Ingredients"
02.22.2017-The Velóce Corporation, developers of the Wireless SmartTab Drug Delivery and Monitoring System, has received notification of the first patent allowance for their proprietary wireless smart polymer drug delivery and monitoring system.
01.23.2017-The Velóce Corporation, developers of the Wireless SmartTab Drug Delivery and Monitoring System, has partnered with Digital Healthcare leader Catalyst HTI http://www.catalysthealthtech.com. Catalyst HTI performs an integral role in building out the World Class Digital Healthcare environment in Denver, Colorado.
01.11.2017-Velóce Corporation attends the StartUp Health/JP Morgan Healthcare Festival in San Francisco. Velóce Founder and CEO, Robert Niichel, being interviewed by San Francisco KPIX CBS at the StartUp Health Festival describing SmartTab technology with the Moonshot initiative. http://mikebiselli.com/2017/01/our-moonshot-moment/
01.02.2017-The Velóce Corporation, developers of the Wireless SmartTab Drug Delivery and Monitoring System, has successfully partnered with StartUp Health http://www.startuphealth.com. StartUp Health is dedicated to improving the Health and Wellbeing of everyone in the world.